| Open Document File Size: 4,41 MBShare Result on Facebook
City Ridgebury Rd Ridgefield / Ridgefield / / Company Boehringer Ingelheim Pharmaceuticals Inc. / TDI / ABBREVIATIONS AE / AEs / / Event FDA Phase / / IndustryTerm treatment / treatment for patients with chronic obstructive pulmonary disease / / MedicalCondition pulmonary and cardiac medication / neoplasms / cardiac arrhythmia / bronchospasm / due neoplasm / supraventricular premature beats / COPD / moderate-to-severe COPD / Neoplasm / cardiac disorders / pulmonary medication / chronic inhaled administrations / pulmonary function / chronic obstructive lung disease / emphysema / chronic obstructive pulmonary disease / COPD exacerbation / ischemic heart disease / COPD BACKGROUND / chronic bronchitis / / Organization FDA / Pulmonary-Allergy-Rheumatology Products Advisory Committee / Modified Medical Research Council / / Person LAMA MACE MCID / / Product COMPLIANCE TO STUDY MEDICATION / FEV1 / July-2014 / RESPIMAT / Respimat® / / ProgrammingLanguage R / / ProvinceOrState Connecticut / Michigan / / Technology pharmacokinetics / PHARMACODYNAMICS / /
SocialTag |
abcd PULMONARY-ALLERGY-RHEUMATOLOGY PRODUCTS ADVISORY COMMITTEE BRIEFING DOCUMENT TIOTROPIUM BROMIDE RESPIMAT® INHALATION SPRAY